Clinical Trial Update: A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing two rifaximin tablets in travelers' diarrhea; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Travelers Diarrhea

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Sandoz | Conditions: Travelers' Diarrhea | Phase 3 | Status: TERMINATED | Results posted: 2019-03-25